Today we launch our new website, announcing a new and exciting product called Trace®

Trace® comes with a clear focus onto the rapidly expanding world of in-home health monitoring.

Trace® is not a gadget, it will deliver real, clinically relevant data about your health from tests measured from whole blood, all within your home. Test methods are directly equivalent to central diagnostic laboratory equipment, and so is the data that the device generates – for the first time, hospital-quality testing will be available within the home. Saving multiple visits to the doctor for routine check ups, and removing the wait for days or weeks for results, Trace® gives you the freedom to check your health on a regular basis, quickly and simply, whenever required.

We have made Trace® into a small, cool, functional, easy to use device and something that sets it apart from existing medical devices. It is designed to fit well within your home, whether on your kitchen table or your night stand as an invaluable ’life companion’.

We start with a menu of HbA1c and Lipids, two essential sets of metrics for regular monitoring of diabetes and cardiovascular diseases. Keeping a close eye on these metrics you can ensure you are within the healthy range through your lifestyle choices, or know that you need to consult your doctor before health problems develop.

Using Trace® only requires a small drop of blood from a finger stick, and gives you access to many possibilities to monitor your health and take greater control. Your data is private and safe, managed through the auxiliary smart phone app. When you go to your doctor you can bring the data, confident that it is the same type and quality of data that a doctor would expect to order from a hospital laboratory.

At Atonomics we have many years’ experience building small agile devices for near-patient testing. With Trace® we have put this clinical and biochemical experience into a package with the size and cost that make it suitable for home use. However the biochemical principles are the same as are used for diagnosis in a hospital laboratory – our contribution really lies in miniaturization, simplification and cost reduction without compromise to the test methods. For this reason we expect a relatively simple route to regulatory approvals, utilizing methods and technologies that are already approved and in use today. Trace® is currently at an advanced prototype stage, expected to achieve CE mark and the start of pilot use within 2015. You can find more on our timelines and plans elsewhere on this site.

We will be updating this blog with news of our development and commercialization progress. We will soon add the possibility for a dialogue with you, and would value your input and thoughts on this new device and its possibilities.

Read on to find out more about Trace®, the testing menu now and for future, how it works and when it will be out there.

The Atonomics Team

Newsletter

Sign-up now for our newsletter